Cryptogenic fibrosing alveolitis: pathogenetic mechanisms and therapeutic approaches.
Haslam
P L
PL
Dept. of Cardiothoracic Surgery, National Heart and Lung Institute, London, UK.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology; D001992:Bronchoalveolar Lavage Fluid / Q000473:pathology; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008214:Lymphocytes / Q000276:immunology; D011379:Prognosis; D011658:Pulmonary Fibrosis / Q000188:drug therapy* / Q000276:immunology* / Q000473:pathology
D000305:Adrenal Cortex Hormones; D001323:Autoantibodies; D007136:Immunoglobulins; D007166:Immunosuppressive Agents